Pennington pointed out in his motion that the DEA approved as witnesses officials from Nebraska, which opposes ...

The DEA could allow more participants to testify at upcoming hearings concerning marijuana rescheduling in addition to the ...

Every party that applied to argue against rescheduling marijuana has full standing to participate in an upcoming landmark ...

It seems there are some shenanigans in the government, and now a lawsuit says DEA acting in bad faith over marijuana.

DEA and anti-cannabis group must respond to allegations of unlawful talks by November 25. Legal tensions rise ahead of ...

The group sees Schedule III as "inadequate" for veterans' needs. But the DEA excluded it from the witness list, and a judge ...

The cannabis industry is concerned about the direction of regulations – and the DEA is still against the plant.

The filing asserts that the DEA is compromised and has failed to maintain a complete record and ensure fairness and ...

The rulemaking process that could lead to reclassifying marijuana is lengthy and includes a hearing in DEA administrative court. It is expected to happen in January or February, according to an ...

The DEA did not respond to requests for comment ... Trump and his controversial pick for attorney general have signaled support for reclassifying marijuana, breaking with establishment GOP leaders.

Now a lawsuit says DEA acting in bad faith over marijuana. David Heldreth, CEO of psychedelic research firm Panacea Plant Sciences, claims the DEA’s recent actions violate federal law and ...